Kingworld Medicines Group Limited (HKG:1110)
0.4000
+0.0050 (1.27%)
Sep 11, 2026, 4:08 PM HKT
Kingworld Medicines Group Revenue
Kingworld Medicines Group had revenue of 275.37M CNY in the half year ending June 30, 2026, a decrease of -47.66%. This brings the company's revenue in the last twelve months to 787.87M, down -16.17% year-over-year. In the year 2025, Kingworld Medicines Group had annual revenue of 917.34M, down -13.55%.
Revenue (ttm)
787.87M CNY
Revenue Growth
-16.17%
P/S Ratio
0.26
Revenue / Employee
1.11M CNY
Employees
711
Market Cap
236.99M HKD
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 917.34M | -143.74M | -13.55% |
| Dec 31, 2024 | 1.06B | -17.58M | -1.63% |
| Dec 31, 2023 | 1.08B | 120.96M | 12.63% |
| Dec 31, 2022 | 957.70M | 110.32M | 13.02% |
| Dec 31, 2021 | 847.39M | 102.00M | 13.68% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| JD Health International | 91.25B |
| Alibaba Health Information Technology | 38.94B |
| YSB Inc. | 24.72B |
| Fangzhou | 4.45B |
| Shanghai Pioneer Holding | 1.43B |
| Tycoon Group Holdings | 1.08B |
| Universal Health International Group Holding | 597.78M |
| New Ray Medicine International Holding | 199.09M |